Arcadia Biosciences Stock Shares Owned By Insiders
| RKDA Stock | USD 2.10 0.14 7.14% |
Arcadia Biosciences fundamentals help investors to digest information that contributes to Arcadia Biosciences' financial success or failures. It also enables traders to predict the movement of Arcadia Stock. The fundamental analysis module provides a way to measure Arcadia Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arcadia Biosciences stock.
Arcadia | Shares Owned By Insiders |
Arcadia Biosciences Company Shares Owned By Insiders Analysis
Arcadia Biosciences' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Arcadia Biosciences Shares Owned By Insiders | 2.49 % |
Most of Arcadia Biosciences' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arcadia Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Arcadia Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Arcadia Biosciences is extremely important. It helps to project a fair market value of Arcadia Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Arcadia Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Arcadia Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Arcadia Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 2.49% of Arcadia Biosciences are shares owned by insiders. This is 84.18% lower than that of the Food Products sector and 87.93% lower than that of the Consumer Staples industry. The shares owned by insiders for all United States stocks is 75.32% higher than that of the company.
Arcadia Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arcadia Biosciences' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arcadia Biosciences could also be used in its relative valuation, which is a method of valuing Arcadia Biosciences by comparing valuation metrics of similar companies.Arcadia Biosciences is currently under evaluation in shares owned by insiders category among related companies.
Arcadia Fundamentals
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (2.62) % | ||||
| Operating Margin | (2.40) % | ||||
| Current Valuation | (8.11 M) | ||||
| Shares Outstanding | 1.36 M | ||||
| Shares Owned By Insiders | 2.49 % | ||||
| Shares Owned By Institutions | 20.53 % | ||||
| Number Of Shares Shorted | 4.08 K | ||||
| Price To Earning | 4.84 X | ||||
| Price To Book | 0.21 X | ||||
| Price To Sales | 0.50 X | ||||
| Revenue | 5.33 M | ||||
| Gross Profit | (2.22 M) | ||||
| EBITDA | (12.88 M) | ||||
| Net Income | (13.16 M) | ||||
| Cash And Equivalents | 21.23 M | ||||
| Cash Per Share | 0.96 X | ||||
| Total Debt | 1.01 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 6.34 X | ||||
| Book Value Per Share | 9.99 X | ||||
| Cash Flow From Operations | (15.29 M) | ||||
| Short Ratio | 0.15 X | ||||
| Earnings Per Share | (10.64) X | ||||
| Price To Earnings To Growth | (0.08) X | ||||
| Target Price | 11.0 | ||||
| Number Of Employees | 21 | ||||
| Beta | 0.61 | ||||
| Market Capitalization | 2.66 M | ||||
| Total Asset | 19.7 M | ||||
| Retained Earnings | (271.84 M) | ||||
| Working Capital | 11.38 M | ||||
| Current Asset | 52.02 M | ||||
| Current Liabilities | 3.45 M | ||||
| Net Asset | 19.7 M |
About Arcadia Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arcadia Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arcadia Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arcadia Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arcadia Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arcadia Biosciences' short interest history, or implied volatility extrapolated from Arcadia Biosciences options trading.
Currently Active Assets on Macroaxis
When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:Check out Arcadia Biosciences Piotroski F Score and Arcadia Biosciences Altman Z Score analysis. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.Note that the Arcadia Biosciences information on this page should be used as a complementary analysis to other Arcadia Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Arcadia Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.63) | Earnings Share (10.64) | Revenue Per Share 4.309 | Quarterly Revenue Growth 0.573 | Return On Assets (0.34) |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.